NCT06073145

Brief Summary

The main objective of this research is to measure the Doppler signal by the ultrasonic patch. Blood flow measurement is critical for vasospasm, stroke, and embolism monitoring on patients in the ICU or understanding the neurovascular coupling on different subjects. Currently, A conventional transcranial Doppler (TCD) probe is widely used for these applications. A headset design must be applied and fixed on the participants to obtain stable blood flow spectra. However, the TCD headset is operator dependent. The operator needs to be a trained expert and hold the ultrasound probe to get accurate blood flow velocity information. The stretchable and wearable non-invasive ultrasonic patch can not only free the operator's hands but can also provide long-term continuous monitoring, which is not possible by using the current operator-dependent ultrasound machine. The device can be conformal to the skin and attached to the skin surface.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 27, 2022

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

September 13, 2023

Completed
27 days until next milestone

First Posted

Study publicly available on registry

October 10, 2023

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 2, 2024

Completed
6 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 8, 2024

Completed
Last Updated

April 10, 2024

Status Verified

April 1, 2024

Enrollment Period

1.5 years

First QC Date

September 13, 2023

Last Update Submit

April 8, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Device comparison to standard monitoring (conventional transcranial Doppler)

    Clinical feasibility of the measurements from the non-invasive ultrasound patch in comparison to a conventional transcranial Doppler probe on 60 participants. Specifically, the blood flow specturm of different arterial segments including middle cerebral artery, anterior cerebral artery, posterior cerebral artery, vertebral artery, basal artery, internal carotid artery, and ophthalmic artery will be measured by the wearable ultrasound patch and the conventional transcranial Doppler probe. The agreement of these two device on peak systolic velocity, mean flow velocity, and end diastolic velocity of the measurements will be evaulated using the Bland-Altman plot.

    1.5 years

Study Arms (1)

Blood flow monitoring in the brain

A group/cohort of 60 participants will be recruited. The group/cohort has a broad range distribution of different physiological parameters, such as age, gender, race, BMI, and etc.

Device: conventional transcranial Doppler probe and wearable ultrasound patch.

Interventions

Comparison of the measurements from conventional transcranial Doppler probe and wearable ultrasound patch.

Blood flow monitoring in the brain

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants without any serious medical conditions.

You may qualify if:

  • Able to provide informed consent.
  • In relatively good health with no serious medical conditions.

You may not qualify if:

  • Inability to sign the informed consent.
  • History of the following conditions: Heart attack, low blood pressure, aortic stenosis/carotid artery stenosis (also known as heart valve disease), glaucoma (a group of eye conditions that damage the optic nerve) or retinopathy (a disease of the eye retina).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Structural and Materials Engineering (SME) building Room 310

San Diego, California, 92122, United States

Location

MeSH Terms

Conditions

Brain InjuriesBrain DiseasesStroke

Condition Hierarchy (Ancestors)

Central Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemWounds and InjuriesCerebrovascular DisordersVascular DiseasesCardiovascular Diseases

Study Officials

  • Sheng Xu, PhD

    University of California, San Diego

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

September 13, 2023

First Posted

October 10, 2023

Study Start

September 27, 2022

Primary Completion

April 2, 2024

Study Completion

April 8, 2024

Last Updated

April 10, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will share

The study protocol, statistical analysis plan, and clinical study report will be shared and discussed in the research articles.

Shared Documents
STUDY PROTOCOL, SAP, CSR
Time Frame
1.5 years
Access Criteria
Anyone can access it through research articles.

Locations